In theory, dead tumor cells are typically immune-tolerant or non-immunogenic, and under ICD induction, DCCs recruit antigen-presenting cells (APCs) and effector CD4+ and CD8+ T cells by releasing tumor-associated antigens and cytokines through damage-associated molecular patterns (DAMPs). This evidence concerns the gene CD8A and neoplasm.